Jan 8, 2025 · Medicare drug plans can now cover Eli Lilly 's blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on Wednesday. That opens the door for broader access to Zepbound,...

In a statement to CNBC, a spokesperson for the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services, said "current Medicare Part D and Medicaid coverage rules apply" to Zepbound following its landmark approval in December for the most common sleep-related breathing disorder.

Jan 10, 2025 · Popular Eli Lilly (LLY) weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and Drug Administration (FDA) approval last month.

Jan 12, 2025 · CMS announced that Medicare drug plans (Part D or Medicare Advantage) could now cover Zepbound (tirzepatide) when doctors prescribe it to patients for obesity and sleep apnea. This is not the opening of floodgates. It is movement from an absolute “no” to “maybe.”

2 days ago · Does Medicare Cover Zepbound? Medicare coverage can be complex, and it varies based on specific plans and individual circumstances. Generally, Medicare Part B may cover certain medications administered in a clinical setting, while Part D covers outpatient prescriptions.

Jan 8, 2025 · Zepbound met that new criteria last month after the FDA approved it as the first prescription medication to address moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. It...

Jan 9, 2025 · Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the blockbuster weight-loss treatment.

Jan 8, 2025 · Zepbound, a ⁢drug that has seen⁤ skyrocketing demand despite its steep $1,000 monthly price tag, is now eligible for Medicare Part D coverage—but with a catch. The ‌drug can only ⁢be covered if it’s prescribed for obstructive sleep apnea (OSA), a …

Jan 8, 2025 · Zepbound met that new criteria last month after the FDA approved it as the first prescription medication to address moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. It...

Zepbound met that new criteria last month after the FDA approved it as the first prescription medication to address moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. It...